GRDX
Entero Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.26M
P/E Ratio
—
EPS
$-11.66
Beta
—
52W High
$5.84
52W Low
$0.97
50-Day MA
$2.55
200-Day MA
$2.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Entero Therapeutics, Inc.
GridAI Technologies Corp. The company is headquartered in Edinburgh, United Kingdom.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 0.36 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -0.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $3.36M |
| Float | 0 |
| % Insiders | 14.94% |
| % Institutions | 5.22% |
Data last updated: 4/8/2026